To the editor,

We would like to share ideas on the publication “Pre-operative COVID-19

screening: a model to provide non-discretionary care for urologic patients” Ferenczi et al. (¹1 Ferenczi BA, Cheng RR, Daily A, Kuhr C, Kobashi K, Corman JM. Pre-operative COVID-19 screening: a model to provide non-discretionary care for urologic patients. Int Braz J Urol. 2021; 47:631-6.). concluded that “Universal COVID-19screening of pre-operative patients represents aviable means to meet the needs of our patients” (¹1 Ferenczi BA, Cheng RR, Daily A, Kuhr C, Kobashi K, Corman JM. Pre-operative COVID-19 screening: a model to provide non-discretionary care for urologic patients. Int Braz J Urol. 2021; 47:631-6.). Since COVID-19 might be asymptomatic, a COVID-19 screening is a useful preventive measure. Nevertheless, there are some important considerations. First, the cost of screening should be considered. A cost effective screening tool should be selected. Second, any test can provide a false result and limitation of sensitivity might be problematic (²2 Jia X, Xiao L, Liu Y. False negative RT-PCR and false positive antibody tests-Concern and solutions in the diagnosis of COVID-19. J Infect. 2021; 82:414-51.). Universal preventive guidelines are still important. The practitioner has to strict follow the standard universal prevention protocols. Finally, it is necessary to set a good method for management of a positive case. If a positive result is the cause of under standardized clinical management, it is considered unethical. Since there is no present recommendation for specific therapy for COVID-19, further researches are necessary (³3 Gotera C. Treatment and research lines for the patient with COVID-19. What do we have and where are we going? Int Braz J Urol. 2020; 46(suppl.1):125-32.).

The Authors

REFERENCES

Publication Dates

History